A Randomized Controlled Pharmacist Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cognitive Impairment
- Sponsor
- Umeå University
- Enrollment
- 460
- Locations
- 2
- Primary Endpoint
- Number of Patients Readmitted Because of Drug Related Reasons
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The aim of this randomized controlled study is to investigate if medication reviews performed by a clinical pharmacist as part of a ward team can reduce drug related problems and reduce readmissions to hospital among elderly patients (≥65 years) with dementia and cognitive failure.
Four hundred and sixty patients will be recruited and randomized to control (usual care) and intervention group (enhanced service in which a pharmacist is part of the health care team).
Six months after the last patient of the 460 has been discharged the study will be closed. Data about the number of readmissions and visits to the emergency room will be collected during the six-month follow-up and also, the costs associated with each visit or admission. Time until institutionalization will be compared between intervention group and control group.
Investigators
Hugo Lovheim
Principal Investigator
Umeå University
Eligibility Criteria
Inclusion Criteria
- •Patients with dementia or cognitive impairment
- •Patients ≥ 65 years
Exclusion Criteria
- •Patients previously admitted to the study wards during the study period
Outcomes
Primary Outcomes
Number of Patients Readmitted Because of Drug Related Reasons
Time Frame: Six months follow-up
Secondary Outcomes
- Frequency of Emergency Department Visits During the 6-month Follow-up.(Six months follow-up)
- Change in the Number of Participants With Potentially Inappropriate Medications, According to the Swedish National Board of Health and Welfare, at Admission and Discharge Between Intervention and Control Group(Index admission (at randomization) and index discharge (duration of index admission, mean days 8.7))
- Cost for Visits for Readmissions and to the Emergency Department Compared Between Patients in the Control Group and Intervention Group.(Six months follow-up)
- Number of Participants Institutionalized After Discharge, in Control Group and Intervention Group.(Six months follow-up)